Your session is about to expire
← Back to Search
Scalp Cooling for Chemotherapy-Induced Hair Loss
Study Summary
This trialis testing methods to improve scalp cooling efficacy in cancer patients with skin of color, to reduce chemotherapy-induced hair loss.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I will start a chemotherapy treatment with taxane for more than 4 cycles.I have been diagnosed with early to mid-stage breast or lung cancer.I am scheduled for intense chemotherapy or radiation therapy targeting my skull.I am currently on HER, cisplatin, and cyclophosphamide treatments.I can take care of myself but may struggle with hard physical activities.I have previously received chemotherapy or drugs like doxorubicin.This criterion excludes individuals with curly or kinky hair types.I have a history of migraines, anorexia, severe anemia, uncontrolled diabetes, hepatitis, thyroid issues, cold urticaria, cold agglutinin disease, or scalp metastases.I use hair weave/extensions and don't plan to remove them.I do not have any other types of cancer, including blood cancers.I am currently on HER, cisplatin, and cyclophosphamide treatments.Your hair type is not curly or tightly curled.I have mild hair loss.I am older than 18 years.Criterion: Your hair is curly or kinky.I have been diagnosed with stage IV breast cancer or non-small cell lung cancer.
- Group 1: Scalp cooling with hairstyle
- Group 2: Scalp Cooling with conditioner and water emulsion
- Group 3: No Scalp Cooling
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there remaining vacancies in this trial for participants?
"Accurate. The data hosted on clinicaltrials.gov indicates that recruitment for this medical experiment is currently in progress, with the initial posting having taken place on October 24th 2022 and an edit to its specifications taking place just recently on December 22nd 2022."
What is the magnitude of participants in this clinical exploration?
"Affirmative. Information on clinicaltrials.gov shows that the medical trial is currently enrolling participants, with the initial listing posted on October 24th 2022 and last updated December 22nd 2022. The study requires 30 individuals to be recruited from 1 site."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger